相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
Baptist Gallwitz
DRUG SAFETY (2010)
EXENATIDE-INDUCED ACUTE PANCREATITIS
Walaa A. Ayoub et al.
ENDOCRINE PRACTICE (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Orlistat for Overweight Subjects with Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
Stephen A. Harrison et al.
HEPATOLOGY (2009)
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
William W. Shields et al.
Therapeutic Advances in Gastroenterology (2009)
Incretin mimetics as a novel therapeutic option for hepatic steatosis
Maarten E. Tushuizen et al.
LIVER INTERNATIONAL (2006)
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
R. E. Ratner et al.
DIABETES OBESITY & METABOLISM (2006)
Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
OG Kolterman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
